Related Experiment Video
Updated: May 3, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Diagnosis and classification of polyarteritis nodosa
José Hernández-Rodríguez1, Marco A Alba1, Sergio Prieto-González1
1Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Polyarteritis nodosa (PAN) is a rare vasculitis affecting medium arteries, often idiopathic or linked to hepatitis B. Diagnosis relies on biopsy or angiography, with treatment involving corticosteroids and immunosuppressants.
Area of Science:
- Rheumatology
- Immunology
- Pathology
Background:
- Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis affecting medium-sized arteries.
- It is typically negative for anti-neutrophil cytoplasmic antibodies and not associated with glomerulonephritis.
- PAN can be triggered by viral infections, notably hepatitis B virus, but is often idiopathic.
Purpose of the Study:
- To review the key features, diagnostic approaches, and current treatment strategies for Polyarteritis Nodosa.
- To highlight the challenges in classification and the ongoing efforts to develop new diagnostic criteria.
Main Methods:
- Review of clinical manifestations, laboratory findings, and diagnostic modalities for PAN.
- Discussion of current treatment policies, including corticosteroids and immunosuppressive agents.
- Analysis of recent advancements in classification criteria, including the EULAR/ACR initiative.
Main Results:
- PAN presents with multisystemic manifestations, commonly affecting peripheral nerves and skin.
- Histologic confirmation via biopsy of symptomatic organs (skin, muscle, nerve) is preferred for diagnosis.
- Visceral angiography may reveal micro-aneurysms when biopsies are inconclusive.
Conclusions:
- PAN requires a high index of suspicion due to its varied presentation and non-specific laboratory findings.
- Treatment involves a combination of corticosteroids and immunosuppressants, tailored to organ involvement.
- New international diagnostic and classification criteria are under development to improve accuracy and address limitations of previous criteria.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Nephrotic Syndrome II : Assessment and Medical Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Pyelonephritis II: Diagnostic Studies and Management

